Administration of recombinant erythropoietin to a patient with malignant lymphoma who refused blood transfusion.

Bibliographic Information

Other Title
  • 輸血拒否例に対する化学療法でのエリスロポエチン併用の試み

Search this article

Abstract

A 30-year-old female patient with malignant lymphoma was admitted to the hospital because of large mass in the left pelvic cavity and of severe anemia. Since she had refused blood transfusion (Jehovah's witness), recombinant human erythropoietin (Epo) was used together with both chemotherapy and irradiation; this led to rapid recovery of the anemia and marked reduction of the mass volume. These findings may suggest the possible application of Epo administration as a supportive therapy in treatment of malignancy.

Journal

  • Rinsho Ketsueki

    Rinsho Ketsueki 31 (10), 1698-1700, 1990

    The Japanese Society of Hematology

Details 詳細情報について

Report a problem

Back to top